A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients
Public ClinicalTrials.gov record NCT00634348. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Four-Week Double Blind Multicenter Study Comparing The Efficacy And Safety Of Ziprasidone To Aripiprazole In Subjects With Schizophrenia Or Schizoaffective Disorder Needing Inpatient Care
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the efficacy and safety of ziprasidone and aripiprazole in hospitalized patients with schizophrenia or schizoaffective disorder
Study identification
- NCT ID
- NCT00634348
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 256 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- Mar 2005 (Actual)
- Last update posted
- Feb 21, 2021
2004 – 2005
United States locations
- U.S. sites
- 41
- U.S. states
- 13
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Anaheim | California | 92804 | — |
| Pfizer Investigational Site | Cerritos | California | 90703 | — |
| Pfizer Investigational Site | Culver City | California | 90232 | — |
| Pfizer Investigational Site | Garden Grove | California | 92845 | — |
| Pfizer Investigational Site | Glendale | California | 91206 | — |
| Pfizer Investigational Site | La Mesa | California | 91942 | — |
| Pfizer Investigational Site | Newport Beach | California | 92663 | — |
| Pfizer Investigational Site | Paramount | California | 90723 | — |
| Pfizer Investigational Site | Riverside | California | 92506 | — |
| Pfizer Investigational Site | San Diego | California | 92105 | — |
| Pfizer Investigational Site | San Diego | California | 92123 | — |
| Pfizer Investigational Site | San Diego | California | 92126 | — |
| Pfizer Investigational Site | Torrance | California | 90505 | — |
| Pfizer Investigational Site | Upland | California | 91786 | — |
| Pfizer Investigational Site | Washington D.C. | District of Columbia | 20016 | — |
| Pfizer Investigational Site | Hialeah | Florida | 33016 | — |
| Pfizer Investigational Site | Shreveport | Louisiana | 71101 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21202 | — |
| Pfizer Investigational Site | Rockville | Maryland | 20850 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63104 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63118 | — |
| Pfizer Investigational Site | Clementon | New Jersey | 08021 | — |
| Pfizer Investigational Site | Princeton | New Jersey | 08540 | — |
| Pfizer Investigational Site | Willingboro | New Jersey | 08046 | — |
| Pfizer Investigational Site | Woodlane | New Jersey | 08060 | — |
| Pfizer Investigational Site | Jamaica | New York | 11418 | — |
| Pfizer Investigational Site | Staten Island | New York | 10305 | — |
| Pfizer Investigational Site | Butner | North Carolina | 27509 | — |
| Pfizer Investigational Site | Chapel Hill | North Carolina | 27599-7160 | — |
| Pfizer Investigational Site | Durham | North Carolina | 27705 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27603 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45220 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45267-0559 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73118 | — |
| Pfizer Investigational Site | Bellaire | Texas | 77401 | — |
| Pfizer Investigational Site | Dallas | Texas | 75228 | — |
| Pfizer Investigational Site | Houston | Texas | 77008 | — |
| Pfizer Investigational Site | Irving | Texas | 75062 | — |
| Pfizer Investigational Site | Arlington | Virginia | 22204 | — |
| Pfizer Investigational Site | Arlington | Virginia | 22205 | — |
| Pfizer Investigational Site | Falls Church | Virginia | 22041 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00634348, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 21, 2021 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00634348 live on ClinicalTrials.gov.